Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04258150 |
|---|---|
| Brief Title: | Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer (TRIPPLE-R) |
| First Submitted : | February 4, 2020 |
| First Submitted that Met QC Criteria : | February 5, 2020 |
| First Posted : | February 6, 2020 |
| Last Update Submitted that Met QC Criteria : | March 15, 2022 |
| Last Update Posted : | March 31, 2022 |